MedPath

A study on Siddha trial drug Pooranathi Chooranam (INT),Vali Kuthaluku Ulli Ennai (EXT)and Ottradam in patients having neck pain

Phase 2
Not yet recruiting
Conditions
Saganavatham (Cervical Spondylosis)
Registration Number
CTRI/2018/05/013642
Lead Sponsor
Government Siddha Medical College
Brief Summary

This is an open clinical study to evaluate the efficacy of Pooranathi chooranam (Internal) and Vali kuthaluku Ulli Ennai (External)... Pooranathi chooranam and sufficient quantity of Vali kuthaluku Ulli Ennai will be given for 48 days. Ottradam therapy is given for all the patients. Sample size is 40. The trial drugs Pooranathi chooranam and vali kuthaluku Ulli Ennai contain some active herbs having anti inflammatory and analgesic properties which will be cure Cervical spondylosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Complain about dull pain behind the neck in the area of trapezius 2.Radiating pain to the upper limbs 3.
  • Numbness and weakness in arms, hands and fingers 4.Giddiness 5.Muscle spasms in neck and shoulders.
Exclusion Criteria

History of 1.Cervical rib 2.Trauma 3.Spina bifida 4.Cardiac disease 5.Fracture 6.Ankylosing spondylosis (stright spine) 7.Malignancy 8.Pregnancy and Lactation 9.Tuberculosis in spine 10.Adhesive capsulitis 11.Carpal tunnel syndrome 12.Patient with any other serious systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is reduction of pain in neck which by assessed Visual analog scale.12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Government siddha medical college

🇮🇳

Chennai, TAMIL NADU, India

Government siddha medical college
🇮🇳Chennai, TAMIL NADU, India
Dr R Kalaivani
Principal investigator
9786725977
kalaivanibsms92@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.